Pembrolizumab 790mg/4.8ml solution for injection vials
- SNOMED code
45750711000001107- Active compound
- Pembrolizumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 4.8 ml, vial
- Ingredients
- Pembrolizumab
— 165 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninjection.subcutaneous
Solution for injection, Subcutaneous - Controlled drug
- No Controlled Drug Status
Products
Keytruda 790mg/4.8ml solution for injection vials (Merck Sharp & Dohme (UK) Ltd)
Keytruda 790mg/4.8ml solution for injection vials
- SNOMED code
45733211000001109- Supplier
- Merck Sharp & Dohme (UK) Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Subcutaneous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Keytruda 790mg/4.8ml solution for injection vials (Merck Sharp & Dohme (UK) Ltd) 1 vial45733311000001101 ref. pack | 💯 Available Legal category: POM | 036658251248600366582512486 | NHS Indicative Price £10,520 | • Hospital |
| — |
Reference packs
Pembrolizumab 790mg/4.8ml solution for injection vials 1 vial
- SNOMED code
45733111000001103- Quantity and unit
- 1 vial
- Packs